A Study to Evaluate the Safety Tolerability and Immunogenicity of a Modified RNA (mRNA) Vaccine Against Influenza
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Influenza
-
Age: Between 65 years - 100 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Are willing to receive a research flu vaccine (not licensed by the FDA)
- Have not received a licensed or investigational influenza vaccine within the past 6 months
You may not be eligible for this study if the following are true:
-
- Medical or psychiatric condition including recent (within the past year) or active suicidal thoughts/behavior or health conditions that may increase the risk of potential study risks or, in the investigator’s judgment, make the participant unsuitable for the study
- History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (e.g., anaphylaxis) to any component of the study intervention(s)
- Immunocompromised individuals with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination
- Allergy to egg proteins (egg or egg products) or chicken proteins.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.